SERPINB2 and colorectal carcinoma: The evidence suggested that ID1 inhibits the transcription of SerpinB2 and CCL4 in macrophages to promote tumor immune evasion and augment the tumor-initiating capacity of CRC cells, ultimately resulting in aggravated tumor growth and metastasis.